Revenue,
USD USD 22.06 Bn
Forecast Year,
USD USD 35.93 Bn
CAGR, 2025 -
5%
Report Coverage
Worldwide
Non-Steroidal Anti-Inflammatory Drugs Market Size Analysis
Non-Steroidal Anti-Inflammatory Drugs Market Size By Disease Type 2024 to 2034 (USD )
| Disease Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Arthritis | 11.03 | 11.58 | 12.15 | 12.75 | 13.39 | 14.05 | 14.75 | 15.48 | 16.24 | 17.05 | 17.89 |
| Migraine | 5.51 | 5.80 | 6.09 | 6.40 | 6.72 | 7.07 | 7.43 | 7.80 | 8.20 | 8.62 | 9.06 |
| Ophthalmic Diseases | 3.31 | 3.48 | 3.65 | 3.84 | 4.03 | 4.24 | 4.45 | 4.68 | 4.91 | 5.16 | 5.43 |
| Others | 2.21 | 2.31 | 2.43 | 2.55 | 2.67 | 2.80 | 2.94 | 3.08 | 3.23 | 3.39 | 3.56 |
Non-Steroidal Anti-Inflammatory Drugs Market Size By Route of Administration 2024 to 2034 (USD )
| Route of Administration | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oral | 15.44 | 16.21 | 17.01 | 17.85 | 18.74 | 19.67 | 20.64 | 21.66 | 22.74 | 23.86 | 25.05 |
| Topical | 5.51 | 5.80 | 6.09 | 6.40 | 6.72 | 7.07 | 7.43 | 7.80 | 8.20 | 8.62 | 9.06 |
| Others | 1.10 | 1.16 | 1.22 | 1.28 | 1.35 | 1.42 | 1.50 | 1.57 | 1.66 | 1.74 | 1.83 |
Non-Steroidal Anti-Inflammatory Drugs Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacy | 9.93 | 10.43 | 10.95 | 11.51 | 12.09 | 12.70 | 13.34 | 14.01 | 14.72 | 15.46 | 16.24 |
| Retail Pharmacy | 8.82 | 9.26 | 9.72 | 10.20 | 10.70 | 11.23 | 11.79 | 12.37 | 12.98 | 13.63 | 14.30 |
| Online Pharmacy | 3.31 | 3.47 | 3.65 | 3.83 | 4.02 | 4.22 | 4.43 | 4.66 | 4.89 | 5.13 | 5.39 |
Non-Steroidal Anti-Inflammatory Drugs Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 8.38 | 8.82 | 9.27 | 9.75 | 10.25 | 10.78 | 11.34 | 11.93 | 12.54 | 13.19 | 13.87 |
| Europe | 5.96 | 6.24 | 6.55 | 6.86 | 7.20 | 7.55 | 7.91 | 8.29 | 8.70 | 9.12 | 9.56 |
| Asia-Pacific | 4.85 | 5.11 | 5.37 | 5.66 | 5.95 | 6.26 | 6.59 | 6.94 | 7.30 | 7.68 | 8.09 |
| Latin America | 1.54 | 1.61 | 1.69 | 1.76 | 1.84 | 1.93 | 2.02 | 2.11 | 2.20 | 2.30 | 2.41 |
| Middle East & Africa | 1.32 | 1.38 | 1.44 | 1.50 | 1.57 | 1.63 | 1.70 | 1.78 | 1.85 | 1.93 | 2.01 |
Non-Steroidal Anti-Inflammatory Drugs Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com